Bessemer Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-30
Closed -$10K 2165
2024
Q1
$10K Hold
30
﹤0.01% 1564
2023
Q4
$6K Buy
30
+28
+1,400% +$5.29K ﹤0.01% 1742
2023
Q3
$0 Sell
2
-27
-93% -$6.38K ﹤0.01% 2378
2023
Q2
$8K Buy
+29
New +$8.05K ﹤0.01% 1714
2023
Q1
Sell
-32
Closed -$7K 2106
2022
Q4
$7K Sell
32
-19,008
-100% -$4.81M ﹤0.01% 1510
2022
Q3
$5.29M Buy
19,040
+19,023
+111,900% +$4.84M 0.01% 314
2022
Q2
$3K Buy
+17
New +$3K ﹤0.01% 1714
2022
Q1
Sell
-5
Closed -$1K 1990
2021
Q4
$1K Sell
5
-48
-91% -$9.47K ﹤0.01% 1838
2021
Q3
$11K Buy
+53
New +$10.4K ﹤0.01% 1364

Other funds holding SWAV

Bessemer Group's SWAV Position: Q2 2024 in Review

Bessemer Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 30 shares — an estimated $10K sold.

Bessemer Group first reported a position in SWAV in Q3 2021 and held it in 9 quarters. The position peaked at $5.29M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Bessemer Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bessemer Group sold 30 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $10K.
  • Bessemer Group first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Bessemer Group's Shockwave Medical, Inc. Common Stock position peaked at $5.29M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Bessemer Group's 13F filing for Q2 2024, filed 13 Aug 2024.